The mechanistic target of rapamycin (mTOR) pathway coordinates cell growth, metabolism and synaptic plasticity in the central nervous system. Dysregulation of mTOR signalling, often through mutations ...
A newly published study in Genes & Diseases highlights the crucial role of the mammalian target of rapamycin (mTOR) pathway in the progression of diabetic nephropathy (DN) and explores its potential ...
Network map of 29 authors with frequency greater than five. Nodes represent authors, and the larger the node, the higher the number of papers. The lines represent collaborations with other authors, ...
Vitamin D deficiency and bone loss post gastrectomy for gastroesophageal malignancy. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract does not include a full text ...
Combining IL-12 immunocytokine (M9241) with docetaxel in metastatic prostate cancer: A phase I study. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not ...
Oncotarget published "Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the ...
The mTOR protein becomes excessively active in cancer cells, driving tumor growth and metastasis. The molecular mechanisms by ...
Interrupting one function of a protein that plays a key role in cell signaling could enable the development of new cancer treatments, according to a study led by Dr. Martin Taylor at the Warren Alpert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results